Treatment of Ptosis as a Complication of Botulinum Toxin Injection

ABSTRACT In this case report, we present one of the complications of botulinum toxin injection. Botulinum toxin injection could be used in the treatment of migraine headaches and this use could be complicated by ptosis. Botulinum toxin type A was injected into the frontalis, orbicularis oculi, corru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pain medicine (Malden, Mass.) Mass.), 2005-03, Vol.6 (2), p.149-151
Hauptverfasser: Omoigui, Sota, Irene, Sunday
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 151
container_issue 2
container_start_page 149
container_title Pain medicine (Malden, Mass.)
container_volume 6
creator Omoigui, Sota
Irene, Sunday
description ABSTRACT In this case report, we present one of the complications of botulinum toxin injection. Botulinum toxin injection could be used in the treatment of migraine headaches and this use could be complicated by ptosis. Botulinum toxin type A was injected into the frontalis, orbicularis oculi, corrugator supercillis, and temporalis muscles bilateral, as well as into the procerus muscle, in a patient with chronic migraine headache. Three days later the patient developed ptosis, conjunctival injection and pain initially in one eye, later involving both eyes. This complication was successfully treated after 9 days of instilling apraclonidine 0.5% ophthalmic solution and dexamethasone 0.1%/tobramycin 0.3% ophthalmic suspension into both eyes.
doi_str_mv 10.1111/j.1526-4637.2005.05029.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19842300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19842300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5439-d55733fa0f375eef687656dcc3448e4ad0adf55a1fc3983438e1c3a1b00d07753</originalsourceid><addsrcrecordid>eNqNkM9LwzAUx4MoTqf_gvTkrfWlSZr04MGNqYOJO8xzyNIEUtpmNi1u_72tG3r18eA9-H7fDz4IRRgSPMRDmWCWZjHNCE9SAJYAgzRP9mfo6lc4P_Up4WyCrkMoAXBGBblEE8w4J0LAFZptWqO62jRd5G207nxwIVJDRnNf7yqnVed8M2oz3_WVa_o62vi9a6JlUxo9ijfowqoqmNtTnaKP58Vm_hqv3l-W86dVrBkleVwwxgmxCuzwkDE2EzxjWaE1oVQYqgpQhWVMYatJLgglwmBNFN4CFMA5I1N0f9y7a_1nb0Inaxe0qSrVGN8HiXNBUwIwGMXRqFsfQmus3LWuVu1BYpAjP1nKEY0cMcmRn_zhJ_fD6N3pRr-tTfE3eAI2GB6Phi9XmcO_F8v122LsyDeimH3K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19842300</pqid></control><display><type>article</type><title>Treatment of Ptosis as a Complication of Botulinum Toxin Injection</title><source>MEDLINE</source><source>Wiley Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Omoigui, Sota ; Irene, Sunday</creator><creatorcontrib>Omoigui, Sota ; Irene, Sunday</creatorcontrib><description>ABSTRACT In this case report, we present one of the complications of botulinum toxin injection. Botulinum toxin injection could be used in the treatment of migraine headaches and this use could be complicated by ptosis. Botulinum toxin type A was injected into the frontalis, orbicularis oculi, corrugator supercillis, and temporalis muscles bilateral, as well as into the procerus muscle, in a patient with chronic migraine headache. Three days later the patient developed ptosis, conjunctival injection and pain initially in one eye, later involving both eyes. This complication was successfully treated after 9 days of instilling apraclonidine 0.5% ophthalmic solution and dexamethasone 0.1%/tobramycin 0.3% ophthalmic suspension into both eyes.</description><identifier>ISSN: 1526-2375</identifier><identifier>EISSN: 1526-4637</identifier><identifier>DOI: 10.1111/j.1526-4637.2005.05029.x</identifier><identifier>PMID: 15773880</identifier><language>eng</language><publisher>Oxford, UK and Malden, USA: Blackwell Science Inc</publisher><subject>Apraclonidine ; Blepharoptosis - chemically induced ; Blepharoptosis - drug therapy ; Botulinum Toxin ; Botulinum Toxins, Type A - adverse effects ; Botulinum Toxins, Type A - therapeutic use ; Clonidine - analogs &amp; derivatives ; Clonidine - therapeutic use ; Female ; Humans ; Injections, Intramuscular ; Middle Aged ; Migraine ; Migraine Disorders - drug therapy ; Naphthalenes - therapeutic use ; Ophthalmic Solutions - therapeutic use ; Pain - chemically induced ; Pain - prevention &amp; control ; Ptosis ; Tobramycin - therapeutic use ; Treatment Outcome</subject><ispartof>Pain medicine (Malden, Mass.), 2005-03, Vol.6 (2), p.149-151</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5439-d55733fa0f375eef687656dcc3448e4ad0adf55a1fc3983438e1c3a1b00d07753</citedby><cites>FETCH-LOGICAL-c5439-d55733fa0f375eef687656dcc3448e4ad0adf55a1fc3983438e1c3a1b00d07753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1526-4637.2005.05029.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1526-4637.2005.05029.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15773880$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Omoigui, Sota</creatorcontrib><creatorcontrib>Irene, Sunday</creatorcontrib><title>Treatment of Ptosis as a Complication of Botulinum Toxin Injection</title><title>Pain medicine (Malden, Mass.)</title><addtitle>Pain Med</addtitle><description>ABSTRACT In this case report, we present one of the complications of botulinum toxin injection. Botulinum toxin injection could be used in the treatment of migraine headaches and this use could be complicated by ptosis. Botulinum toxin type A was injected into the frontalis, orbicularis oculi, corrugator supercillis, and temporalis muscles bilateral, as well as into the procerus muscle, in a patient with chronic migraine headache. Three days later the patient developed ptosis, conjunctival injection and pain initially in one eye, later involving both eyes. This complication was successfully treated after 9 days of instilling apraclonidine 0.5% ophthalmic solution and dexamethasone 0.1%/tobramycin 0.3% ophthalmic suspension into both eyes.</description><subject>Apraclonidine</subject><subject>Blepharoptosis - chemically induced</subject><subject>Blepharoptosis - drug therapy</subject><subject>Botulinum Toxin</subject><subject>Botulinum Toxins, Type A - adverse effects</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Clonidine - analogs &amp; derivatives</subject><subject>Clonidine - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intramuscular</subject><subject>Middle Aged</subject><subject>Migraine</subject><subject>Migraine Disorders - drug therapy</subject><subject>Naphthalenes - therapeutic use</subject><subject>Ophthalmic Solutions - therapeutic use</subject><subject>Pain - chemically induced</subject><subject>Pain - prevention &amp; control</subject><subject>Ptosis</subject><subject>Tobramycin - therapeutic use</subject><subject>Treatment Outcome</subject><issn>1526-2375</issn><issn>1526-4637</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkM9LwzAUx4MoTqf_gvTkrfWlSZr04MGNqYOJO8xzyNIEUtpmNi1u_72tG3r18eA9-H7fDz4IRRgSPMRDmWCWZjHNCE9SAJYAgzRP9mfo6lc4P_Up4WyCrkMoAXBGBblEE8w4J0LAFZptWqO62jRd5G207nxwIVJDRnNf7yqnVed8M2oz3_WVa_o62vi9a6JlUxo9ijfowqoqmNtTnaKP58Vm_hqv3l-W86dVrBkleVwwxgmxCuzwkDE2EzxjWaE1oVQYqgpQhWVMYatJLgglwmBNFN4CFMA5I1N0f9y7a_1nb0Inaxe0qSrVGN8HiXNBUwIwGMXRqFsfQmus3LWuVu1BYpAjP1nKEY0cMcmRn_zhJ_fD6N3pRr-tTfE3eAI2GB6Phi9XmcO_F8v122LsyDeimH3K</recordid><startdate>200503</startdate><enddate>200503</enddate><creator>Omoigui, Sota</creator><creator>Irene, Sunday</creator><general>Blackwell Science Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>200503</creationdate><title>Treatment of Ptosis as a Complication of Botulinum Toxin Injection</title><author>Omoigui, Sota ; Irene, Sunday</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5439-d55733fa0f375eef687656dcc3448e4ad0adf55a1fc3983438e1c3a1b00d07753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Apraclonidine</topic><topic>Blepharoptosis - chemically induced</topic><topic>Blepharoptosis - drug therapy</topic><topic>Botulinum Toxin</topic><topic>Botulinum Toxins, Type A - adverse effects</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Clonidine - analogs &amp; derivatives</topic><topic>Clonidine - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intramuscular</topic><topic>Middle Aged</topic><topic>Migraine</topic><topic>Migraine Disorders - drug therapy</topic><topic>Naphthalenes - therapeutic use</topic><topic>Ophthalmic Solutions - therapeutic use</topic><topic>Pain - chemically induced</topic><topic>Pain - prevention &amp; control</topic><topic>Ptosis</topic><topic>Tobramycin - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Omoigui, Sota</creatorcontrib><creatorcontrib>Irene, Sunday</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pain medicine (Malden, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Omoigui, Sota</au><au>Irene, Sunday</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Ptosis as a Complication of Botulinum Toxin Injection</atitle><jtitle>Pain medicine (Malden, Mass.)</jtitle><addtitle>Pain Med</addtitle><date>2005-03</date><risdate>2005</risdate><volume>6</volume><issue>2</issue><spage>149</spage><epage>151</epage><pages>149-151</pages><issn>1526-2375</issn><eissn>1526-4637</eissn><abstract>ABSTRACT In this case report, we present one of the complications of botulinum toxin injection. Botulinum toxin injection could be used in the treatment of migraine headaches and this use could be complicated by ptosis. Botulinum toxin type A was injected into the frontalis, orbicularis oculi, corrugator supercillis, and temporalis muscles bilateral, as well as into the procerus muscle, in a patient with chronic migraine headache. Three days later the patient developed ptosis, conjunctival injection and pain initially in one eye, later involving both eyes. This complication was successfully treated after 9 days of instilling apraclonidine 0.5% ophthalmic solution and dexamethasone 0.1%/tobramycin 0.3% ophthalmic suspension into both eyes.</abstract><cop>Oxford, UK and Malden, USA</cop><pub>Blackwell Science Inc</pub><pmid>15773880</pmid><doi>10.1111/j.1526-4637.2005.05029.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1526-2375
ispartof Pain medicine (Malden, Mass.), 2005-03, Vol.6 (2), p.149-151
issn 1526-2375
1526-4637
language eng
recordid cdi_proquest_miscellaneous_19842300
source MEDLINE; Wiley Journals; Oxford University Press Journals All Titles (1996-Current)
subjects Apraclonidine
Blepharoptosis - chemically induced
Blepharoptosis - drug therapy
Botulinum Toxin
Botulinum Toxins, Type A - adverse effects
Botulinum Toxins, Type A - therapeutic use
Clonidine - analogs & derivatives
Clonidine - therapeutic use
Female
Humans
Injections, Intramuscular
Middle Aged
Migraine
Migraine Disorders - drug therapy
Naphthalenes - therapeutic use
Ophthalmic Solutions - therapeutic use
Pain - chemically induced
Pain - prevention & control
Ptosis
Tobramycin - therapeutic use
Treatment Outcome
title Treatment of Ptosis as a Complication of Botulinum Toxin Injection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Ptosis%20as%20a%20Complication%20of%20Botulinum%20Toxin%20Injection&rft.jtitle=Pain%20medicine%20(Malden,%20Mass.)&rft.au=Omoigui,%20Sota&rft.date=2005-03&rft.volume=6&rft.issue=2&rft.spage=149&rft.epage=151&rft.pages=149-151&rft.issn=1526-2375&rft.eissn=1526-4637&rft_id=info:doi/10.1111/j.1526-4637.2005.05029.x&rft_dat=%3Cproquest_cross%3E19842300%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19842300&rft_id=info:pmid/15773880&rfr_iscdi=true